does oral retatrutide work โฑ๏ธ๐ How Fast Work? What the Clinical Data Shows ๐ฌ๐ Retatrutide is a next-generation triple-agonist therapy targeting GLP-1, GIP, and glucagon receptors designed to accelerate fat loss and metabolic improvement What is the use and
Description
Imamura, S., Hirai, K
Managing Side Effects While Serving If you are cleared to take a GLP-1 medication, managing the transition is key to maintaining your performance

Patience combined with consistent daily dosing produces the best outcomes

Current Atherosclerosis Reports
At 48 weeks, 93% of participants taking 12 mg retatrutide achieved normal liver fat levels (below 5%), compared to 0% in the placebo group

Stay Informed Subscribe to the ISMP Canada Safety Bulletins and Newsletters
